Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ergomed Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ergomed Plc, Medical Devices Deals, 2012 to YTD 2018 10
Ergomed Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Ergomed Plc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Haemostatix Raises USD0.1 Million in Venture Financing 13
Partnerships 15
Ergomed Enters into Co-Development Agreement with Allergy Therapeutics 15
Ergomed Enters into Co-Development Agreement with Asarina Pharma 16
Ergomed Enters into Co-Development Agreement with Dilaforette 17
Ergomed Clinical Research Enters Into Co-Development Agreement With Ferrer 18
Cel-Sci Enters Into Co-Development Agreement With Ergomed For Multikine In HIV/HPV Co-Infected Patients With Peri-Anal Warts 19
Cel-Sci Enters Into Co-Development Agreement With Ergomed For Multikine 20
Cel-Sci Expands Co-Development Agreement with Ergomed 21
Aeterna Zentaris Enters Into Co-Development Agreement With Ergomed Clinical Research For AEZS-108 22
Licensing Agreements 23
Ergomed Enters into Licensing Agreement with Boryung Pharma 23
Equity Offering 24
Ergomed Raises USD5.5 Million in Private Placement of Shares 24
Ergomed Raises USD2.2 Million in Private Placement of Shares 25
Ergomed Announces Underwriter’s Exercise of Over-Allotment Option of Private Placement for USD10.4 Million 26
Ergomed Raises USD19 Million in IPO 27
Acquisition 28
Ergomed Acquires PSR Group for USD6.7 Million 28
Ergomed Acquires Dr.Oestreich +Partner and Gesellschaft fur angewandte Statistik + Datenanalyse 29
Ergomed Acquires Haemostatix 30
Ergomed Acquires Sound Opinion 32
Ergomed Plc – Key Competitors 33
Ergomed Plc – Key Employees 34
Ergomed Plc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 37
Financial Announcements 37
Sep 19, 2018: Ergomed announces unaudited interim results for the six months ended 30 June 2018 37
Apr 11, 2018: Ergomed: Unaudited Preliminary Results for the year ended 31 December 2017 40
Sep 18, 2017: Ergomed: Unaudited Interim results for the six months ended 30 June 2017 41
Mar 28, 2017: Ergomed: Unaudited Preliminary Results for the year ended 31 December 2016 42
Jan 17, 2017: Ergomed to report very strong 2016 revenue growth and order backlog; Poised for significant clinical milestones in 2017 43
Corporate Communications 44
Oct 02, 2018: Michael Spiteri appointed non-executive director to help drive digitization strategy 44
Jul 02, 2018: Ergomed Names Stuart Jackson As Chief Financial Officer 45
Dec 15, 2017: Stephen Stamp appointed as CEO and Jan Petracek as COO 47
Dec 15, 2017: Ergomed Board appointed Stephen Stamp as CEO and Jan Petracek as COO 48
Apr 13, 2017: Ergomed Announces Board and Management Changes 49
Other Significant Developments 50
Jun 15, 2018: Ergomed Announces Registered Office Address Change 50
Mar 05, 2018: Ergomed: Trading Update and Notice of Preliminary Results 51
Jan 25, 2018: Ergomed 2017 Trading Update 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
Ergomed Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ergomed Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ergomed Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Ergomed Plc, Medical Devices Deals, 2012 to YTD 2018 10
Ergomed Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Haemostatix Raises USD0.1 Million in Venture Financing 13
Ergomed Enters into Co-Development Agreement with Allergy Therapeutics 15
Ergomed Enters into Co-Development Agreement with Asarina Pharma 16
Ergomed Enters into Co-Development Agreement with Dilaforette 17
Ergomed Clinical Research Enters Into Co-Development Agreement With Ferrer 18
Cel-Sci Enters Into Co-Development Agreement With Ergomed For Multikine In HIV/HPV Co-Infected Patients With Peri-Anal Warts 19
Cel-Sci Enters Into Co-Development Agreement With Ergomed For Multikine 20
Cel-Sci Expands Co-Development Agreement with Ergomed 21
Aeterna Zentaris Enters Into Co-Development Agreement With Ergomed Clinical Research For AEZS-108 22
Ergomed Enters into Licensing Agreement with Boryung Pharma 23
Ergomed Raises USD5.5 Million in Private Placement of Shares 24
Ergomed Raises USD2.2 Million in Private Placement of Shares 25
Ergomed Announces Underwriter’s Exercise of Over-Allotment Option of Private Placement for USD10.4 Million 26
Ergomed Raises USD19 Million in IPO 27
Ergomed Acquires PSR Group for USD6.7 Million 28
Ergomed Acquires Dr.Oestreich +Partner and Gesellschaft fur angewandte Statistik + Datenanalyse 29
Ergomed Acquires Haemostatix 30
Ergomed Acquires Sound Opinion 32
Ergomed Plc, Key Competitors 33
Ergomed Plc, Key Employees 34
Ergomed Plc, Subsidiaries 35
List of Figures
Ergomed Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ergomed Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ergomed Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ergomed Plc, Medical Devices Deals, 2012 to YTD 2018 10